Indapamide
Indapamide is a thiazide-like diuretic drug used in the treatment of hypertension, as well as decompensated heart failure. Combination preparations with perindopril (an ACE inhibitor antihypertensive) are available. The thiazide-like diuretics (indapamide and chlorthalidone) reduce risk of major cardiovascular events and heart failure in hypertensive patients compared with hydrochlorothiazide with a comparable incidence of adverse events. Both thiazide diuretics and thiazide-like diuretics are effective in reducing risk of stroke. Both drug classes appear to have comparable rates of adverse effects as other antihypertensives such as angiotensin II receptor blockers and dihydropyridine calcium channel blockers and lesser prevalence of side-effects when compared to ACE-inhibitors and non-dihydropyridine calcium channel blockers.
Clinical data | |
---|---|
Trade names | Lozol, Natrilix |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684062 |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 71–79% |
Metabolism | Liver |
Elimination half-life | 14–18 hours |
Identifiers | |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.043.633 |
Chemical and physical data | |
Formula | C16H16ClN3O3S |
Molar mass | 365.83 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
It was patented in 1968 and approved for medical use in 1977. It is on the World Health Organization's List of Essential Medicines.